Literature DB >> 23105890

Role of reactive oxygen species in pathogenesis of nephrotic syndrome.

Santoshi R Ghodake1, A N Suryakar, R D Ankush, K Shaikh, A V Katta.   

Abstract

Nephrotic syndrome is the common chronic disorder characterized by alteration of permeability of the glomerular capillary wall, resulting in its inability to restrict the urinary loss of proteins. Nephrotic syndrome is characterized by heavy proteinuria, hypoalbuminemia, hyperlipidemia associated with peripheral edema. The molecular basis of glomerular permselectivity remains largely unknown. In recent years it has been proposed that Nephrotic syndrome is a consequence of an imbalance between oxidant and antioxidant activity. The present study was aimed to test that the reactive oxygen species are the mediators of excessive protein permeability and other complications of Nephrotic syndrome. For this 30 adults with Nephrotic syndrome were studied. The control group comprised 30 healthy adults matched for age. Serum levels of lipid peroxides, nitric oxide (NO⊙), α- tocopherol, ascorbic acid, erythrocyte superoxide dismutase activity, serum albumin, uric acid, cholesterol and plasma total antioxidant capacity were measured. Student's 't' test was applied for statistical analysis. There was a significant increase in lipid peroxide (1.58 ± 0.42 in controls, 3.64 ±1.3 in patients) (P<0.001) levels in study group as compared with controls. α-tocopherol (12.95 ± 1.04 in controls, 9.93 ± 1.43 in patients) (P<0.001), erythrocyte SOD activity(1.88 ± 0.9 in controls 1.07 ± 0.5 in patients) (P=0.01), serum albumin(4.06 ± 0.50 in controls, 3.04 ± 0.11 in patients) (P<0.001), and plasma total antioxidant capacity (847.33 ± 126.83 in controls, 684.00±102.94 in patients) (P<0.001) were significantly decreased. There was non-significant increase in uric acid (P>0.05), a non-significant decrease in NO⊙ (38.48 ± 15.47 in controls 37.47 ± 14.27 in patients) (P>0.05) and ascorbic acid levels ascorbic acid,( 0.95 ± 0.31in controls 0.79 ± 0.30 in patients) (P>0.05) in study group as compared with controls. Imbalance between oxidants and antioxidants may contribute to pathogenesis of proteinuria and related complications in nephrotic syndrome.

Entities:  

Keywords:  Antioxidants; Erythrocyte Superoxide dismutase; Lipid peroxide; Nephrotic syndrome

Year:  2010        PMID: 23105890      PMCID: PMC3453014          DOI: 10.1007/s12291-010-0017-y

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  22 in total

1.  Indirect quantification of lipid peroxidation in steroid responsive nephrotic syndrome.

Authors:  S Kinra; B Rath; B C Kabi
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

Review 2.  Renal antioxidant enzymes: their regulation and function.

Authors:  I Ichikawa; S Kiyama; T Yoshioka
Journal:  Kidney Int       Date:  1994-01       Impact factor: 10.612

3.  Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method.

Authors:  N K Cortas; N W Wakid
Journal:  Clin Chem       Date:  1990-08       Impact factor: 8.327

4.  Nitric oxide production is reduced in patients with chronic renal failure.

Authors:  R Wever; P Boer; M Hijmering; E Stroes; M Verhaar; J Kastelein; K Versluis; F Lagerwerf; H van Rijn; H Koomans; T Rabelink
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

5.  The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay.

Authors:  I F Benzie; J J Strain
Journal:  Anal Biochem       Date:  1996-07-15       Impact factor: 3.365

6.  Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome.

Authors:  C J Raats; M A Bakker; J van den Born; J H Berden
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

7.  Glucose and free radicals impair the antioxidant properties of serum albumin.

Authors:  E Bourdon; N Loreau; D Blache
Journal:  FASEB J       Date:  1999-02       Impact factor: 5.191

8.  Oxidative stress status in children with nephrotic syndrome.

Authors:  A Rajbala; A S Sane; J Zope; V V Mishra; H L Trivedi
Journal:  Panminerva Med       Date:  1997-09       Impact factor: 5.197

9.  Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method.

Authors:  K Satoh
Journal:  Clin Chim Acta       Date:  1978-11-15       Impact factor: 3.786

10.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

Authors:  B N Ames; R Cathcart; E Schwiers; P Hochstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

View more
  4 in total

Review 1.  The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio A Brito-Melo; Cayo Antônio Soares de Almeida; Lázaro Lopes Moreira; Cleiton Willian Cordeiro; Thiago Guimarães Rosa Carvalho; Elvis Cueva Mateo; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

2.  Antioxidant status of children with idiopathic nephrotic syndrome.

Authors:  Om P Mishra; Aditya K Gupta; Rajniti Prasad; Ziledar Ali; Ram S Upadhyay; Surendra P Mishra; Narendra K Tiwary; Franz S Schaefer
Journal:  Pediatr Nephrol       Date:  2010-11-21       Impact factor: 3.714

3.  Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio Alvim Brito-Melo; Cláudia Martins Carneiro; Dirceu de Sousa Melo; Karine Beatriz Costa; Fábio Lourenço Tadeu Guimarães; Etel Rocha-Vieira; Érica Leandro Marciano Vieira; Ana Cristina Simões e Silva
Journal:  Mediators Inflamm       Date:  2015-05-07       Impact factor: 4.711

4.  Steroid-sensitive nephrotic syndrome candidate gene CLVS1 regulates podocyte oxidative stress and endocytosis.

Authors:  Brandon M Lane; Megan Chryst-Stangl; Guanghong Wu; Mohamed Shalaby; Sherif El Desoky; Claire C Middleton; Kinsie Huggins; Amika Sood; Alejandro Ochoa; Andrew F Malone; Ricardo Vancini; Sara E Miller; Gentzon Hall; So Young Kim; David N Howell; Jameela A Kari; Rasheed Gbadegesin
Journal:  JCI Insight       Date:  2022-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.